Literature DB >> 29469053

Fontan-Associated Liver Disease: A Review.

Luis Téllez1, Enrique Rodríguez-Santiago1, Agustín Albillos1.   

Abstract

Fontan-associated liver disease is a hepatic disorder arising from hemodynamic changes and systemic venous congestion following Fontan surgery. The histological changes produced in the liver are similar but not equivalent to those seen in other forms of cardiac liver disease. While the natural history of this form of liver disease is not well established, over time many Fontan patients develop portal hypertension-related complications such as ascites, variceal hemorrhage or encephalopathy. Fontan survivors also show an increased risk of hepatocellular carcinoma. Early diagnosis of advanced liver disease is mandatory for the prevention and treatment of complications such as hepatocellular carcinoma, esophageal varices and malnutrition. This review updates current knowledge of the pathophysiology and management of Fontan-associated liver disease including new diagnostic methods and treatments.

Entities:  

Keywords:  Fontan surgery. Liver disease. Hepatocarcinoma. Ascites. Fontan failure.

Mesh:

Year:  2018        PMID: 29469053     DOI: 10.5604/01.3001.0010.8634

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  15 in total

1.  An Emphasis on Screening to Detect Liver Cirrhosis and Hepatocellular Carcinoma in Patients Having Undergone the Fontan Procedure in Early Childhood.

Authors:  Samragnyi Madala; Kira MacDougall; Abhishek Polavarapu; Dinesh Gurala; Vivek Gumaste; Gerard Morvillo
Journal:  Case Rep Gastroenterol       Date:  2020-11-23

Review 2.  Congenital heart disease-associated liver disease: a narrative review.

Authors:  Florian P Reiter; Nino J Hadjamu; Nicole Nagdyman; Reinhart Zachoval; Julia Mayerle; Enrico N De Toni; Harald Kaemmerer; Gerald Denk
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

Review 3.  Screening modalities for the diagnosis of Fontan-associated liver disease: evidence from the past for future development.

Authors:  Saviga Sethasathien; Krit Leemasawat; Suchaya Silvilairat; Rekwan Sittiwangkul; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

4.  Hemodynamic Impact of Atrial Pacing in Patients with Fontan Physiology and Junctional Rhythm: A Cardiac Catheterization Study.

Authors:  Mohammad Alnoor; Grant Burch; Laurie Armsby; Anjan Batra; Seshadri Balaji
Journal:  Pediatr Cardiol       Date:  2021-10-18       Impact factor: 1.655

5.  Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CanHepC), the Canadian Association of Hepatology Nurses (CAHN), and the Canadian NASH Network 2022 Abstracts.

Authors: 
Journal:  Can Liver J       Date:  2022-05-09

6.  Shear wave dispersion to assess liver disease progression in Fontan-associated liver disease.

Authors:  Tomoaki Nagasawa; Hidekatsu Kuroda; Tamami Abe; Hirofumi Saiki; Yasuhiro Takikawa
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

Review 7.  Relationship between Heart Disease and Liver Disease: A Two-Way Street.

Authors:  Hamza El Hadi; Angelo Di Vincenzo; Roberto Vettor; Marco Rossato
Journal:  Cells       Date:  2020-02-28       Impact factor: 6.600

8.  A patient with post-Fontan operation underwent left hepatectomy and caudate lobectomy for hepatocellular carcinoma: a case report.

Authors:  Satoshi Nemoto; Shun-Ichi Ariizumi; Yoshihito Kotera; Akiko Omori; Shingo Yamashita; Taka-Aki Kato; Hiroto Egawa; Masakazu Yamamoto
Journal:  Surg Case Rep       Date:  2020-05-19

9.  Fontan-associated liver disease and hepatocellular carcinoma in adults.

Authors:  Tomomi Kogiso; Katsutoshi Tokushige
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

10.  Repeated TACE in HCC after Fontan surgery and situs viscerum inversus: A case report.

Authors:  Fulvio Gasparrini; Ilaria Lenci; Maria Giulia Gagliardi; Marco Spada; Fabio Salimei; Antonio Orlacchio
Journal:  Radiol Case Rep       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.